MB
Mission BioCapital
Activity from announced rounds
Activity in this selectionFintech
Mission BioCapital is the manager whose Platinum Program portfolio includes Enodia and Cloverleaf.
Recorded funding activity
Enodia develops medicines that degrade proteins during synthesis. Cloverleaf engineers transfer RNA for cancer therapies, while EpiBiologics develops antibodies for extracellular-protein degradation. The manager remains distinct from named funds and programs.
- Rounds participated in
- 0
- Confirmed lead rounds
- — All roles disclosed
- New companies
- 0 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share
By stage
No activity in this selection.
By primary sector
No activity in this selection.
By country
No activity in this selection.
Rounds
0 in this selectionNo rounds match this selection.